TellWell
← Back to feed
Publications2h ago82% confidenceConfidence 82% — the share of independent, credible sources corroborating the core facts.

Study Shows Ketone Bodies Can Independently Sustain Brain Energy Without Glucose

Center 100%
1 source

Researchers using an ex vivo brain preparation found that β-hydroxybutyrate (a ketone body) can independently maintain brain tissue metabolism and function when glucose is absent. The study monitored mitochondrial function and tested tissue resilience by inducing spreading depolarization, a severe metabolic stress. The findings support the potential use of ketogenic approaches in treating neurological disorders involving energy metabolism or glucose availability issues.

A new preprint study published on bioRxiv examined whether ketone bodies can sustain brain metabolism independently of glucose by using an isolated brain tissue preparation supplied only with β-hydroxybutyrate (BHB) as fuel. Researchers monitored mitochondrial function after prolonged exposure to glucose-free conditions and tested tissue resilience by inducing spreading depolarization, a severe energetic challenge requiring rapid restoration of cellular balance. The results showed that mitochondria dynamically regulated oxygen utilization while maintaining sufficient energy reserves to allow brain tissue to generate and recover from repeated spreading depolarizations. These findings demonstrate that ketone bodies alone can support essential metabolic and functional properties of brain tissue, broadening understanding of how the brain can flexibly use different fuel sources. The authors suggest these results provide additional support for ketogenic dietary strategies in neurological conditions where energy metabolism or glucose availability may be compromised.

What's missing

The study uses an ex vivo (isolated tissue) preparation rather than in vivo (whole organism) conditions, which may not fully replicate the complexity of brain metabolism in living animals or humans. The authors acknowledge that resolving this question in vivo is difficult because the body maintains circulating glucose even during starvation through endogenous production, but the extent to which these ex vivo findings translate to intact organisms remains to be determined.

What different sources said

  • bioRxivCenter

    β-Hydroxybutyrate maintains energetically demanding neural functions during glucose deprivation

Related

PublicationsConfidence 82% — the share of independent, credible sources corroborating the core facts.

Study Identifies Galectin-3's Role in Gastric Metaplasia Development Through Cathartocytosis

Researchers found that galectin-3, a protein upregulated in precancerous tissue changes, facilitates a cellular process called cathartocytosis that promotes the development of spasmolytic polypeptide expressing metaplasia (SPEM) in the stomach. Galectin-3 is abnormally expressed alongside sulfated mucins in high-risk precancerous conditions like Barrett's esophagus and intestinal metaplasia. The findings suggest galectin-3 may represent a therapeutic target for preventing progression from normal tissue to metaplastic and potentially cancerous states.

1 source13m ago
PublicationsConfidence 82% — the share of independent, credible sources corroborating the core facts.

Study reveals spermatogonial stem cell clones don't follow random drift patterns in zebrafish

Researchers used CRISPR barcoding to track how spermatogonial stem cells (SSCs) contribute to sperm production across a zebrafish's lifetime, finding that clonal dynamics deviate significantly from neutral drift models. The study developed a mathematical framework showing that larger clones tend to drift at higher rates, suggesting non-random selection pressures. These findings have implications for understanding allele transmission and male fertility across the reproductive lifespan.

1 source26m ago
PublicationsConfidence 88% — the share of independent, credible sources corroborating the core facts.

Researchers identify synthetic lethal TYMS inhibitor effective against ATRX-deficient cells

Scientists developed a phenotype-first screening approach that identified PP12, a covalent fragment that selectively kills ATRX-deficient cells by inhibiting thymidylate synthase (TYMS). The study combines covalent fragment screening, chemoproteomics, and genetic analysis to link drug phenotypes to specific cellular targets. This work establishes a generalizable methodology for discovering synthetic lethal drug candidates in cancer cells with specific genetic deficiencies.

1 source26m ago